TY - JOUR A1 - Koch, Claudia A1 - Asna Ashari, Parsa A1 - Mirtsch, Mona A1 - Blind, K. A1 - Castka, P. T1 - Impact of the COVID-19 pandemic on accredited conformity assessment bodies: insights from a multinational study JF - Accreditation and Quality Assurance N2 - The COVID-19 pandemic posed new and manifold challenges to organizations and their operations worldwide. Conformity assessment bodies (CABs), such as testing or medical laboratories, certification, and inspection bodies, were also affected by the associated disruptions. Their role in this crisis is highly relevant, as CABs are essential pillars of the quality infrastructure: their activities ensure that products and services meet requirements as defined in standards and regulations, thereby contributing to their safety and reliability. The question arises of how CABs and their operations were affected by the pandemic and how they responded. To this end, we present the results of an international survey of 986 CABs of all types in Germany, the UK, Italy, and New Zealand. Overall, CABs reported, on average, a reduction in demand for their services during the pandemic, facing restrictions in all countries. In addition, the pandemic had an overall negative impact on the CABs’ investment and innovation activities. However, investments in digital infrastructure were increased as a countermeasure, with CABs reporting a higher need for digitalization. The paper highlights and discusses results from in-depth analyses relevant to policymakers and industry alike. KW - Quality Infrastructure KW - Digitalization KW - Testing laboratories KW - Conformity assessment KW - Certification KW - Conformity assessment body KW - Corona KW - Covid-19 KW - Resilience PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-556396 DO - https://doi.org/10.1007/s00769-022-01514-x SP - 1 EP - 14 PB - Springer AN - OPUS4-55639 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - RPRT A1 - Koch, Claudia A1 - Ladu, Luana A1 - Asna Ashari, Parsa A1 - Blind, K. A1 - Castka, P. T1 - Digitalization in conformity assessment in Germany - A QI-FoKuS study T1 - Digitalisierung in der Konformitätsbewertung in Deutschland - Eine QI-FoKuS-Studie T2 - Digitalization in conformity assessment worldwide N2 - This report summarizes findings from the first comprehensive study on digitalization in conformity assessment in Germany. The reults are based on data from a survey among conformity assessment bodies (CABs) conducted in 2022. It highlights the digital maturity of the organizations, the motives, benefits and obstacles of digital transformation as well as the actual technology trends. The study on German CABs is part of a global project that covers various other countries (see www.qi-fokus.de). N2 - Dieser Bericht fasst die Ergebnisse der ersten umfassenden Studie zur Digitalisierung der Konformitätsbewertung in Deutschland zusammen. Die Ergebnisse basieren auf Daten einer Umfrage unter Konformitätsbewertungsstellen (KBS), die 2022 durchgeführt wurde. Sie beleuchten den digitalen Reifegrad der Organisationen, die Motive, Vorteile und Hindernisse der digitalen Transformation sowie die aktuellen Technologietrends. Die Studie zu KBS in Deutschland ist Teil eines globalen Projekts, das verschiedene andere Länder umfasst (siehe www.qi-fokus.de). KW - Quality infrastructure KW - Digitalization KW - Testing KW - Conformity assessment KW - Certification KW - Laboratory KW - Digital transformation KW - TIC KW - Conformity assessment body KW - COVID-19 KW - Calibration KW - Corona KW - Digitalisierung KW - Kalibrierung KW - Konformitätsbewertung KW - Konformitätsbewertungsstelle KW - Labor KW - Prüfung KW - Qualitätsinfrastruktur KW - Zertifizierung KW - Digitale Transformation PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-554885 UR - https://www.qi-fokus.de SP - 1 EP - 44 PB - Bundesanstalt für Materialforschung und -prüfung (BAM) CY - Berlin AN - OPUS4-55488 LA - mul AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Fischer, Janina T1 - Suspensionsarray-Fluoreszenzimmunoassay zur Multiplexbestimmung von SARS-CoV-2-Antikörpern T2 - Masterarbeit N2 - Übergeordnetes Ziel der Arbeit war die Entwicklung und Optimierung eines Suspensionsarray-Fluoreszenzimmunoassays (SAFIA) für die simultane Bestimmung verschiedener gegen SARS-CoV-2-Proteine gerichtete Antikörper mittels Multiplexdetektion in komplexen Matrices wie humanen Blutserumproben. KW - SARS-CoV-2 KW - Corona KW - COVID-19 KW - Coronavirus KW - Virus KW - Spike-Protein KW - Nucleocapsid-Protein KW - RBD KW - SAFIA KW - LFIA KW - ELISA KW - Partikel KW - Mutationen KW - Neutralisierende Antikörper KW - Durchflusszytometrie KW - ACE2 PY - 2022 SP - 1 EP - 99 PB - Humboldt-Universität zu Berlin CY - Berlin AN - OPUS4-54722 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -